Related references
Note: Only part of the references are listed.Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
Marina Caskey et al.
NATURE (2015)
Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques
Yvonne Rosenberg et al.
PLOS ONE (2015)
Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variants
Florian Klein et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques
Masashi Shingai et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys
Dan H. Barouch et al.
CELL (2013)
Rapid High-Level Production of Functional HIV Broadly Neutralizing Monoclonal Antibodies in Transient Plant Expression Systems
Yvonne Rosenberg et al.
PLOS ONE (2013)
HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice
Joshua A. Horwitz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Investigational treatment suspension and enhanced cell-mediated immunity at rebound followed by drug-free remission of simian AIDS
Iart Luca Shytaj et al.
RETROVIROLOGY (2013)
Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo
Brian Moldt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus
L. A. Lagenaur et al.
MUCOSAL IMMUNOLOGY (2011)
Cellular Gene Expression Profiles in Rhesus Macaques Challenged Mucosally with a Pathogenic R5 Tropic Simian Human Immunodeficiency Virus Isolate
Hye-Kyung Chung et al.
VIRAL IMMUNOLOGY (2008)
The absorption of darbepoetin alfa occurs predominantly via the lymphatics following subcutaneous administration to sheep
Danielle N. McLennan et al.
PHARMACEUTICAL RESEARCH (2006)
Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn)
William F. Dall'Acqua et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Lymphatic transport of proteins after s.c. injection: implications of animal model selection
CJH Porter et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)